Establishing surrogate markers for fluconazole resistance in Candida albicans

Microbial Drug Resistance

Volumn 11, Issue 3, 2005, Pages 232-238

  Park, Steven ^a   Perlin, David S ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PYRROLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DRUG TRANSPORT; ERG11 GENE; FLU1 GENE; FUNGAL GENE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; GENE OVEREXPRESSION; IMMUNE DEFICIENCY; MDR1 GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS;

ANTIFUNGAL AGENTS; BIOLOGICAL MARKERS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; FLUCONAZOLE; FUNGAL PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION;

CANDIDA; CANDIDA ALBICANS;

EID: 26444574876     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.232     Document Type: Article

References (22)

1. Balashov S.V., R. Gardiner, S. Park, and D.S. Perlin. 2005. Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole. J. Clin. Microbiol. 43:214-222.
2. Calabrese, D., J. Bille, and D. Sanglard. 2000. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole Microbiology. 146:2743-2754.
3. Frade, J.P., D.W. Warnock, and B.A. Arthington-Skaggs. 2004 Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization. J. Clin. Microbiol. 42:2085-2093.
4. Franz, R., S.L. Kelly, D.C. Lamb, D.E. Kelly, M. Ruhnke, and J. Morschhauser. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains Antimicrob Agents Chemother. 42:3065-3072.
5. Franz, R., M. Ruhnke, and J. Morschhauser. 1999. Molecular aspects of fluconazole resistance development in Candida albicans Mycoses. 42:453-458.
6. Loeffler, J., and D.A. Stevens. 2003. Antifungal drug resistance. Clin Infect Dis 36:S31-S41.
7. Lopez-Ribot, J. L., R.K. McAtee, S. Perea, W.R. Kirkpatrick, M.G. Rinaldi, and T.F. Patterson. 1999 Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 43:1621-1630.
8. Marichal, P., L. Koymans, S. Willemsens, D. Bellens, P. Verhasselt, W. Luten, M. Borgers, F.C.S. Ramaekers, F.C. Odds, and H. Vanden Bossche. 1999. Contribution of mutations in the cytochrome P450 14a-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145:2701-2713.
9. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
10. Perlin, D.S., and S. Park. 2001. Rapid identification of fungal pathogens: molecular approaches for a new millennium. Rev. Med. Microbiol. 12:S13-S20.
11. Perea, S., J.L. Lopez-Ribot, W.R. Kirkpatrick, R.K. McAtee, R.A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T.F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients Antimicrob. Agents Chemother. 45:2676-2684.
12. Podust, L. M., T.L. Poulos, and M.R. Waterman. 2001. Crystal structure of cytochrome P450 14-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. USA 98:3068-3073.
13. Safdar, A., V. Chaturvedi, E.W. Cross, S. Park, E.M. Bernard, D. Armstrong, and D.S. Perlin. 2001. Prospective study of Candida species in patients at a comprehensive cancer center Antimicrob. Agents Chemother. 45:2129-2133.
14. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143:405-416.
15. Sanglard, D., F. Ischer, L. Koymans, and J. Bille. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42:241-253.
16. Sanglard, D., F. Ischer, D. Calabrese, M.de Micheli, and J. Bille. 1998. Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Res. Updates 1:255-265.
17. Sanglard, D., and F.C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73-85.
18. Sheehan, D. J., C.A. Hitchcock, and C.M. Sibley. 1999. Current and emerging azole antifungal agents. Clin Microbiol Rev. 12:40-79.
19. Tyagi, S., D.P. Bratu, and F.R. Kramer. 1998. Multicolor molecular beacons for allele discrimination. Nature Biotechnol. 16:49-53.
20. White, T.C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
21. White, T.C., K.A. Marr, and R.A. Bowden. 1998 Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
22. White, T.C., S. Holleman, F. Dy, L.F. Mirels, and D.A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713.